Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 May;58(5):1212-21.
doi: 10.2337/db08-1607. Epub 2009 Feb 17.

Changes in insulin sensitivity and insulin release in relation to glycemia and glucose tolerance in 6,414 Finnish men

Affiliations

Changes in insulin sensitivity and insulin release in relation to glycemia and glucose tolerance in 6,414 Finnish men

Alena Stancáková et al. Diabetes. 2009 May.

Abstract

Objective: We evaluated insulin sensitivity and insulin secretion across the entire range of fasting (FPG) and 2-h plasma glucose (PG), and we investigated the differences in insulin sensitivity and insulin release in different glucose tolerance categories.

Research design and methods: A total of 6,414 Finnish men (aged 57 +/- 7 years, BMI 27.0 +/- 3.9 kg/m2) from our ongoing population-based METSIM (Metabolic Syndrome in Men) study were included. Of these subjects, 2,168 had normal glucose tolerance, 2,859 isolated impaired fasting glucose (IFG), 217 isolated impaired glucose tolerance (IGT), 701 a combination of IFG and IGT, and 469 newly diagnosed type 2 diabetes.

Results: The Matsuda index of insulin sensitivity decreased substantially within the normal range of FPG (-17%) and 2-h PG (-37%) and was approximately -65 and -53% in the diabetic range of FPG and 2-h PG, respectively, compared with the reference range (FPG and 2-h PG <5.0 mmol/l). Early-phase insulin release declined by only approximately -5% within the normal range of FPG and 2-h PG but decreased significantly in the diabetic range of FPG (by 32-70%) and 2-h PG (by 33-51%). Changes in insulin sensitivity and insulin secretion in relation to hyperglycemia were independent of obesity. The predominant feature of isolated IGT was impaired peripheral insulin sensitivity. Isolated IFG was characterized by impaired early and total insulin release.

Conclusions: Peripheral insulin sensitivity was already decreased substantially at low PG levels within the normoglycemic range, whereas impairment in insulin secretion was observed mainly in the diabetic range of FPG and 2-h PG. Obesity did not affect changes in insulin sensitivity or insulin secretion in relation to hyperglycemia.

PubMed Disclaimer

Figures

FIG. 1.
FIG. 1.
Insulin sensitivity (Matsuda ISI) (A and B), early-phase insulin release (InsAUC30/GluAUC30) (C and D), and total insulin release during the OGTT (InsAUC120/GluAUC120) (E and F) across the categories of FPG and 2-h PG. Bars display the value of insulin sensitivity or insulin release relative to the reference category (FPG <5.0 mmol/l, 2-h PG <5.0 mmol/l). Calculations were based on geometric means, adjusted for age and BMI with the general linear model. Cutoff values for different categories of FPG were (in mg/dl): 90.1 (5.0 mmol/l), 99.1 (5.5 mmol/l), 108.1 (6.0 mmol/l), 117.1 (6.5 mmol/l), 126.1 (7.0 mmol/l), 135.1 (7.5 mmol/l), 144.1 (8.0 mmol/l), 153.2 (8.5 mmol/l), and 162.2 (9.0 mmol/l). Cutoff values for different categories of 2-h PG were (in mg/dl): 90.1 (5.0 mmol/l), 108.1 (6.0 mmol/l), 126.1 (7.0 mmol/l), 144.1 (8.0 mmol/l), 162.2 (9.0 mmol/l), 180.2 (10.0 mmol/l), 198.2 (11.0 mmol/l), 216.2 (12.0 mmol/l), and 234.2 (13.0 mmol/l).
FIG. 2.
FIG. 2.
Disposition indexes corresponding to early-phase (DI30 = Matsuda ISI × InsAUC30/GluAUC30) and total insulin release (DI120 = Matsuda ISI × InsAUC120/GluAUC120) across the categories of FPG (A) and 2-h PG (B). Cutoff values for different categories of FPG and 2-h PG are as explained in Fig. 1.
FIG. 3.
FIG. 3.
Insulin sensitivity (Matsuda ISI) (A and B), early-phase insulin release (InsAUC30/GluAUC30) (C and D), and total insulin release in an OGTT (InsAUC120/GluAUC120) (E and F) across the categories of FPG and 2-h PG in nonobese (BMI <27 kg/m2; ▲) and obese subjects (BMI ≥27 kg/m2; ■). Bars display insulin sensitivity or insulin release relative to the reference category (FPG <5.0 mmol/l, 2-h PG <5.0 mmol/l). Calculations were based on geometric means, adjusted for age and BMI, with the general linear model (performed separately in subgroups of nonobese and obese subjects). Cutoff values for different categories of FPG and 2-h PG are as explained in Fig. 1. Ref., reference.
FIG. 4.
FIG. 4.
Insulin sensitivity (Matsuda ISI and 1/HOMA-IR) (A and B), early-phase insulin release (InsAUC30/GluAUC30) (C), total insulin release (InsAUC120/GluAUC120) (D), disposition index for early insulin release (DI30 = Matsuda ISI × InsAUC30/GluAUC30) (E), and disposition index for total insulin release (DI120 = Matsuda ISI × InsAUC120/GluAUC120) (F) in different categories of glucose tolerance. Bars show percentage of each index relative to NGT (reference, 100%). Calculations were based on geometric means, adjusted for age and BMI (ANCOVA). All pairwise comparisons were statistically significant (P < 0.05, Bonferroni post hoc test) except for those marked: *P > 0.05 vs. NGT, †P > 0.05 vs. isolated IFG, ‡P > 0.05 vs. isolated IGT. Ref., reference. IIFG, isolated IFG; IIGT, isolated IGT; NewDM, newly diagnosed diabetes.

Similar articles

Cited by

References

    1. Unwin N, Shaw J, Zimmet P, Alberti KG: Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention. Diabet Med 2002; 19: 708– 723 - PubMed
    1. Genuth S, Alberti KG, Bennett P, Buse J, Defronzo R, Kahn R, Kitzmiller J, Knowler WC, Lebovitz H, Lernmark A, Nathan D, Palmer J, Rizza R, Saudek C, Shaw J, Steffes M, Stern M, Tuomilehto J, Zimmet P; the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 26: 3160– 3167, 2003 - PubMed
    1. Dunstan DW, Zimmet PZ, Welborn TA, De Courten MP, Cameron AJ, Sicree RA, Dwyer T, Colagiuri S, Jolley D, Knuiman M, Atkins R, Shaw JE: The rising prevalence of diabetes mellitus and impaired glucose tolerance: the Australian Diabetes, Obesity and Lifestyle Study. Diabetes Care 2002; 25: 829– 834 - PubMed
    1. Carnevale Schianca GP, Rossi A, Sainaghi PP, Maduli E, Bartoli E: The significance of impaired fasting glucose versus impaired glucose tolerance: importance of insulin secretion and resistance. Diabetes Care 2003; 26: 1333– 1337 - PubMed
    1. Vaccaro O, Riccardi G: Changing the definition of impaired fasting glucose: impact on the classification of individuals and risk definition. Diabetes Care 2005; 28: 1786– 1788 - PubMed

Publication types